Menu
With over 30 years of experience in the fields of Neurology, Neuropsychogeriatrics, and neurobehavioral studies, professor wertman is the leading medical authority of our company Keep reading…
The number of people in the world with Dementia is now reaching 50 million, with 10 million new cases detected every year. The most common form of Dementia is Alzheimer’s, which constitutes 60-70% of the cases.
The prevalence of Dementia and mild cognitive among the elderly (65 and up) is 10-37%.
No cure is currently available, leading to elongated patient suffering,
alongside an increased burden on public health budgets.
The number of people in the world with Dementia is now reaching 50 million, with 10 million new cases detected every year.
Someone in the world develops dementia every 3 seconds.
50 million recorded cases in 2017, with numbers expected to reach 75 million in 2030
Using our method, we’re able to provide dementia patients with a treatment plan, which is then implemented by their doctors.
We provide relief for HMO’s by reducing the average cost per dementia patients by significantly decreasing hospitalization rates.
We provide relief for HMO’s’ families and individuals, helping them take back their freedom and live better lives.
With over 30 years of experience in the fields of Neurology, Neuropsychogeriatrics, and neurobehavioral studies, professor Wertman is the leading medical authority of our company.
A corporate visionary and seasoned innovator of emerging technologies, Mr. Cohen has served as a consultant for over 20 tech companies. His decisive and clear vision powers our company.”
Founder of Taditel Automotive Electronics, which serves most international car manufacturers.
Partner & Director at Shalom Flour Mill, a major industrial player in Israel.
Our solution provides relief using Telemedicine to deliver personalized treatment remotely.
By doing so, we reduce risk and effort for families and individuals coping with Alzheimer’s.
Our solution monitors progress over time and allows ongoing modifications of the treatment program to optimize treatment effectiveness.
We are improving patient care while reducing time spent on communication & planning.
As we collect more data, our AI learns how to take better care of patients, enabling us to improve our quality of service.
Our solution will be able to predict the emergence of Alzheimer’s and Dementia faster and earlier than before.
